An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022206
Company: ALLERGAN

Summary Review

Products on NDA 022206

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RAPAFLO	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	AB	Yes	Yes
RAPAFLO	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	AB	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022206

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/08/2008	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD	Label (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022206lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022206s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022206s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022206s000_SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/15/2020	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022206s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022206Orig1s016ltr.pdf
11/08/2013	SUPPL-13	Manufacturing (CMC)		Label is not available on this site.
07/12/2013	SUPPL-12	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022206s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/022206Orig1s012ltr.pdf
06/24/2013	SUPPL-11	Manufacturing (CMC)		Label is not available on this site.
12/21/2015	SUPPL-10	Manufacturing (CMC)		Label is not available on this site.
12/14/2012	SUPPL-8	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022206s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022206Orig1s008ltr.pdf
03/04/2010	SUPPL-6	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022206s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/022206s006ltr.pdf
02/13/2009	SUPPL-1	Labeling-Package Insert, Labeling-Container/Carton Labels	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022206s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/022206s001ltr.pdf

Labels for NDA 022206

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/15/2020	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022206s016lbl.pdf
07/12/2013	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022206s012lbl.pdf
12/14/2012	SUPPL-8	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022206s008lbl.pdf
03/04/2010	SUPPL-6	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022206s006lbl.pdf
02/13/2009	SUPPL-1	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022206s001lbl.pdf
02/13/2009	SUPPL-1	Labeling-Container/Carton Labels	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022206s001lbl.pdf
10/08/2008	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022206lbl.pdf

Therapeutic Equivalents for NDA 022206

RAPAFLO

CAPSULE;ORAL; 4MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
RAPAFLO	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	Yes	AB	022206	ALLERGAN
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	211060	AJANTA PHARMA LTD
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	209745	AMNEAL PHARMS CO
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	210626	AUROBINDO PHARMA LTD
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	204726	CHARTWELL RX
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	213230	CREEKWOOD PHARMS
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	204793	HETERO LABS LTD V
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	206541	LUPIN LTD
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	211166	MACLEODS PHARMS LTD
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	210687	MSN
SILODOSIN	SILODOSIN	4MG	CAPSULE;ORAL	Prescription	No	AB	209029	PRINSTON INC

CAPSULE;ORAL; 8MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
RAPAFLO	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	Yes	AB	022206	ALLERGAN
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	211060	AJANTA PHARMA LTD
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	209745	AMNEAL PHARMS CO
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	210626	AUROBINDO PHARMA LTD
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	204726	CHARTWELL RX
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	213230	CREEKWOOD PHARMS
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	204793	HETERO LABS LTD V
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	206541	LUPIN LTD
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	211166	MACLEODS PHARMS LTD
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	210687	MSN
SILODOSIN	SILODOSIN	8MG	CAPSULE;ORAL	Prescription	No	AB	209029	PRINSTON INC

Top